Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioning

Clinical trial NCT00781781 · TERMINATED

Trial details

NCT number: NCT00781781
Sponsor: CABYC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft Versus Host Disease

Start date: 2008-07-01
Primary completion: 2008-08-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.